Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which has repeatedly shown ...

Dr. Jeremy Farrar, WHO’s Chief Scientist, emphasized the importance of strengthening country-led R&D and integrating clinical ...

Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028 Report Highlights Insight On More Than ...

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic ...

申请时她拿到了莫纳什大学、阿德莱德大学、塔斯马尼亚大学等多所澳洲名校医学院的面试Offer，同时也拿到了阳光海岸大学的奖学金。 我一直对数学、科学等理科方面感兴趣，同时我也非常喜欢帮助别人。所以医生就是一个非常适合自己的职业。

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Over a decade of clinical data, experience and know-how with lead polyclonal Treg cell therapy PTG-007 in type-1 diabetes will accelerate ...

ASP-2138 is a bispecific antibody targeting CD3 and claudin 18.2 (CLDN18.2). It is administered through intravenous drip ...

英矽智能创始人兼首席执行官Alex Zhavoronkov博士表示：“ ...

A new study provides important insight into how amyloid-beta and tau proteins impact brain activity and possibly contribute to cognitive decline in Alzheimer's disease.

研究成果以“通过综合临床与临床前研究鉴定FerroTerminator1分子为治疗代谢功能障碍相关脂肪性肝炎的潜在药物（Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH）”为题，2024年8月13日在线发表于《细胞代谢》（Cell ...